Catalent | CTLT

Stock Price
55.80
Daily Change
-0.14 -0.25%
Monthly
-1.06%
Yearly
31.73%
Q2 Forecast
55.37
Peers Price Chg Day Year Date
A Agilent 136.33 -1.22 -0.89% 2.41% Apr/25
ANTM Elevance Health 539.80 6.00 1.12% 19.32% Apr/25
AZN AstraZeneca 11,978.00 -48.00 -0.40% 1.54% Apr/26
BMY Bristol-Myers Squibb 44.70 -4.16 -8.51% -34.28% Apr/25
BRKR Bruker 80.53 -1.67 -2.03% 3.92% Apr/25
CI Cigna 354.51 1.96 0.56% 42.85% Apr/25
CNC Centene 75.68 -0.56 -0.73% 13.58% Apr/25
CRL Charles River Laboratories 227.76 -11.87 -4.95% 21.79% Apr/25
CTLT Catalent 55.80 -0.14 -0.25% 31.73% Apr/25
DGX Quest Diagnostics 135.67 -1.98 -1.44% -7.61% Apr/25
DHR Danaher 245.47 -4.90 -1.96% 5.59% Apr/25
GSK Glaxosmithkline 40.91 0.05 0.12% 13.86% Apr/25
HOLX Hologic 75.71 -1.07 -1.39% -10.84% Apr/25
HUM Humana 311.50 -4.84 -1.53% -37.91% Apr/25
ILMN Illumina 121.03 -1.85 -1.51% -42.63% Apr/25
IQV IQVIA Holdings 233.48 -7.37 -3.06% 22.90% Apr/25
ISRG Intuitive Surgical 371.49 -2.02 -0.54% 25.95% Apr/25
JNJ J&J 146.84 -1.73 -1.16% -9.70% Apr/25
LH Laboratory Of America 198.49 -9.35 -4.50% -10.49% Apr/25
LLY Eli Lilly 729.01 -8.11 -1.11% 93.75% Apr/25
LONN Lonza 522.00 8.20 1.60% -5.02% Apr/26
MCK McKesson 540.22 4.44 0.83% 50.38% Apr/25
MRK Merck 151.95 1.85 1.23% -5.27% Apr/26
MRK Merck 130.49 3.59 2.83% 15.04% Apr/25
MTD Mettler Toledo International 1,234.98 0.28 0.02% -15.51% Apr/25
NOVN Novartis 89.35 -0.65 -0.72% -2.19% Apr/26
PFE Pfizer 25.26 -0.97 -3.69% -34.61% Apr/25
PKI Revvity 102.32 -0.52 -0.51% -19.76% Apr/25
RGEN Repligen 165.70 -2.16 -1.29% 11.48% Apr/25
ROG Roche Holding 219.40 0.60 0.27% -20.56% Apr/26
SUPN Supernus Pharmaceuticals 29.30 -0.96 -3.17% -20.27% Apr/25
TMO Thermo Fisher Scientific 571.73 -6.35 -1.10% 7.24% Apr/25
UNH UnitedHealth 493.54 5.74 1.18% 2.19% Apr/25
WAT Waters 308.53 -1.57 -0.51% 5.40% Apr/25
WST West Pharmaceutical Services 368.66 -17.78 -4.60% 3.20% Apr/25
XRAY Dentsply International 30.35 -0.60 -1.92% -25.85% Apr/25

Indexes Price Day Year Date
MID US400 2887 -13.99 -0.48% 18.79% Apr/25
SPX US500 5084 -23.21 -0.46% 22.95% Apr/26

Catalent traded at $55.80 this Thursday April 25th, decreasing $0.14 or 0.25 percent since the previous trading session. Looking back, over the last four weeks, Catalent lost 1.06 percent. Over the last 12 months, its price rose by 31.73 percent. Looking ahead, we forecast Catalent to be priced at 55.37 by the end of this quarter and at 52.26 in one year, according to Trading Economics global macro models projections and analysts expectations.

Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.